APOE and Alzheimer disease: Heparin and HS accelerate the formation of Aβ fibrils [26–28] and loss of this heparin-APOE binding interaction has been suggested as a possible mechanism for the resistance to AD of the APOE Christchurch loss-of-function mutation recently described in a PSEN1 ADAD mutation carrier [58].